PolyPid Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011326795
USD
3.94
0.16 (4.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PolyPid Ltd. stock-summary
stock-summary
PolyPid Ltd.
Pharmaceuticals & Biotechnology
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Company Coordinates stock-summary
Company Details
18 Hasivim Street,, P.O Box 7126 PETAH TIKVA None : 4959376
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.0%)

Foreign Institutions

Held by 5 Foreign Institutions (10.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mrs. Anat Segal
Chairperson of the Board
Mr. Amir Weisberg
Chief Executive Officer, Director
Mr. Jack Kyiet
Chief Operating Officer, Director
Dr. Noam Emanuel
Chief Technology Officer, Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 35 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.08

stock-summary
Return on Equity

-203.05%

stock-summary
Price to Book

1.72